---
title: "LB Pharmaceuticals Inc (LBRX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/LBRX.US.md"
symbol: "LBRX.US"
name: "LB Pharmaceuticals Inc"
industry: "Pharmaceuticals"
---

# LB Pharmaceuticals Inc (LBRX.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [lbpharma.us](https://lbpharma.us) |

## Company Profile

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -35.51 | 218/256 | - | - | - |
| PB | 2.15 | 93/256 | 1.82 | 1.69 | 1.35 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-09T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 75% |
| Overweight | 1 | 25% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 23.34 |
| Highest Target | 78.00 |
| Lowest Target | 31.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/LBRX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/LBRX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/LBRX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.